Invasive Ventilator Segment Held Largest Share of Asia Pacific Ventilator Market in 2019
According to a new market research study of “Asia Pacific Ventilator Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Mobility, Type, Interface, Mode, and End User” the market is projected to reach US$1,843.10 million by2027 from US$556.25 million in2019. The market is estimated to grow at a CAGR of 13.7% from 2020 to 2027. The report highlights trends prevailing in the Asia Pacific Ventilator market and the factors driving market along with those that act as hindrances.
Based on the interface, the Asia Pacific Ventilator market, is segmented into invasive, and non-invasive ventilator. The invasive ventilator segment held the largest share of the market in 2019, whereas the non-invasive ventilator segment is anticipated to register the highest CAGR in the market during the forecast period. Invasive ventilation can become a lifesaving intervention for patients suffering from respiratory and breathing difficulties. The term ‘invasive‘ means involvement of any instrument penetrating via the mouth ( an endotracheal tube), nose, or the skin (a tracheostomy tube) to serve as an artificial airway. Invasive ventilation through tracheostomy is usually used in infants and children with congenital heart disease or parenchymal lung. It is also used in young children who need continuous mechanical ventilation, those with extreme craniofacial malformations (or other causes of the upper airway or central obstruction of the airway that cannot be fixed by NIV) and those with developmental severe disorders. Noninvasive ventilatory support uses various interfaces and continued evolution with its modifications based on patient comfort and efficacy. Previously, the noninvasive interfaces primarily used were nasal and oronasal masks. During noninvasive ventilation (NIV) for acute respiratory failure, the patient's comfort may be less important than the efficacy of the treatment. However, mask fit and care are required for the prevention of skin damage and air leaks that can reduce patient tolerance and the efficacy of NIV. Hence, the non-invasive segment is to show the highest CAGR in the forecast period.
The growth of the market is attributed to some key driving factors such as high rise in incidences of respiratory illnesses and sudden outbreak of coronavirus pandemic. However, the high costs associated with ventilators is expected to hinder the market growth.
Vyaire Medical, Inc, Hamilton Medical, and Smith’s Group plc. are among the leading companies operating in the Asia Pacific ventilator market.
The report segments Asia Pacific ventilator market as follows:
By Mobility
By Interface
By Country
Reasons to Buy
According to a new market research study of “Asia Pacific Ventilator Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Mobility, Type, Interface, Mode, and End User” the market is projected to reach US$1,843.10 million by2027 from US$556.25 million in2019. The market is estimated to grow at a CAGR of 13.7% from 2020 to 2027. The report highlights trends prevailing in the Asia Pacific Ventilator market and the factors driving market along with those that act as hindrances.
Based on the interface, the Asia Pacific Ventilator market, is segmented into invasive, and non-invasive ventilator. The invasive ventilator segment held the largest share of the market in 2019, whereas the non-invasive ventilator segment is anticipated to register the highest CAGR in the market during the forecast period. Invasive ventilation can become a lifesaving intervention for patients suffering from respiratory and breathing difficulties. The term ‘invasive‘ means involvement of any instrument penetrating via the mouth ( an endotracheal tube), nose, or the skin (a tracheostomy tube) to serve as an artificial airway. Invasive ventilation through tracheostomy is usually used in infants and children with congenital heart disease or parenchymal lung. It is also used in young children who need continuous mechanical ventilation, those with extreme craniofacial malformations (or other causes of the upper airway or central obstruction of the airway that cannot be fixed by NIV) and those with developmental severe disorders. Noninvasive ventilatory support uses various interfaces and continued evolution with its modifications based on patient comfort and efficacy. Previously, the noninvasive interfaces primarily used were nasal and oronasal masks. During noninvasive ventilation (NIV) for acute respiratory failure, the patient's comfort may be less important than the efficacy of the treatment. However, mask fit and care are required for the prevention of skin damage and air leaks that can reduce patient tolerance and the efficacy of NIV. Hence, the non-invasive segment is to show the highest CAGR in the forecast period.
The growth of the market is attributed to some key driving factors such as high rise in incidences of respiratory illnesses and sudden outbreak of coronavirus pandemic. However, the high costs associated with ventilators is expected to hinder the market growth.
Vyaire Medical, Inc, Hamilton Medical, and Smith’s Group plc. are among the leading companies operating in the Asia Pacific ventilator market.
The report segments Asia Pacific ventilator market as follows:
By Mobility
- Intensive Care Ventilators
- Portable/Transportable VentilatorsBy Type
- Adult/Paediatric Ventilators
- Neonatal/InfantBy Mode
- Combined Mode Ventilation
- Volume Mode Ventilation
- Pressure Mode Ventilation
- Neurally Adjusted Ventilatory Assist (NAVA)
- Inverse Ratio Ventilation (IRV)
- Prone Ventilation
- High-Frequency Oscillatory Ventilation (HFOV)
- High-Frequency Percussive Ventilation (HFPV)
- Others
By Interface
- Invasive
- Non-InvasiveBy End User
- Hospitals and Clinics
- Home Care
- Ambulatory Care Centers
- Emergency Medical Services (EMS)
By Country
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
Reasons to Buy
- To understand the Asia Pacific ventilator market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for ventilator market.
- Efficiently plan M&A and partnership deals in Asia Pacific ventilator market by identifying market segments with the most promising probable sales.
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific ventilator market.
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in Asia Pacific region
Table of Contents
1. Introduction
3. Research Methodology
4. Asia PacificVentilator Market - Market Landscape
5. Asia PacificVentilator Market - Key Market Dynamics
6. Ventilator Market - Asia Pacific Analysis
7. Asia PacificVentilator Market Analysis and Forecasts To 2027 - By Mobility
8. Asia PacificVentilator Market Analysis - By Type
9. Asia PacificVentilator Market Analysis - By Interface
10. VentilatorMarket Analysis - By Mode
11. VentilatorMarket Analysis - By End User
12. Ventilator Market Revenue and Forecasts To 2027 - Geographical Analysis
13. Impact Of COVID-19 Pandemic on Asia Pacific Ventilator Market
14. Company Profiles
15. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Vyaire Medical, Inc
- General Electric Company
- Getinge AB
- Dragerwerk AG & Co. KGaA
- Fisher & Paykel Healthcare Limited
- Hamilton Medical
- Koninklijke Philips N.V
- Medtronic
- ResMed
- Smiths Group plc